The New York Times, October 12, 2020 (Virginia Hughes, Katie Thomas, and Katherine J. Wu)
Johnson & Johnson has paused the large late-stage clinical trial of its coronavirus vaccine because of an “unexplained illness” in one of the volunteers, the company said on Monday.
The company did not say whether the sick participant had received the experimental vaccine or a placebo. The pause was first reported by the health news website Stat. On Tuesday morning, shares of Johnson & Johnson fell about 2 percent on the S&P 500.